• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cells . The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident Lung Megakaryocyte Up-Regulation in the Microthrombosis Mecha

tetano

Editor, Senior Moderator
Cells


. 2024 May 17;13(10):854.
doi: 10.3390/cells13100854. The Role of TLR-2 in Lethal COVID-19 Disease Involving Medullary and Resident Lung Megakaryocyte Up-Regulation in the Microthrombosis Mechanism

Giuseppe Pannone[SUP] 1 [/SUP], Maria Carmela Pedicillo[SUP] 1 [/SUP], Ilenia Sara De Stefano[SUP] 1 [/SUP], Francesco Angelillis[SUP] 1 [/SUP], Raffaele Barile[SUP] 2 [/SUP], Chiara Pannone[SUP] 3 [/SUP], Giuliana Villani[SUP] 4 [/SUP], Francesco Miele[SUP] 5 [/SUP], Maurizio Municinò[SUP] 6 [/SUP], Andrea Ronchi[SUP] 7 [/SUP], Gaetano Serviddio[SUP] 2 [/SUP], Federica Zito Marino[SUP] 7 [/SUP], Renato Franco[SUP] 7 [/SUP], Tommaso Colangelo[SUP] 2 8 [/SUP], Rosanna Zamparese[SUP] 9 [/SUP]



Affiliations
Abstract

Patients with COVID-19 have coagulation and platelet disorders, with platelet alterations and thrombocytopenia representing negative prognostic parameters associated with severe forms of the disease and increased lethality.
Methods: The aim of this study was to study the expression of platelet glycoprotein IIIa (CD61), playing a critical role in platelet aggregation, together with TRL-2 as a marker of innate immune activation.
Results: A total of 25 patients were investigated, with the majority (24/25, 96%) having co-morbidities and dying from a fatal form of SARS-CoV-2(+) infection (COVID-19+), with 13 men and 12 females ranging in age from 45 to 80 years. When compared to a control group of SARS-CoV-2 (-) negative lungs (COVID-19-), TLR-2 expression was up-regulated in a subset of patients with deadly COVID-19 fatal lung illness. The proportion of Spike-1 (+) patients found by PCR and ISH correlates to the proportion of Spike-S1-positive cases as detected by digital pathology examination. Furthermore, CD61 expression was considerably higher in the lungs of deceased patients. In conclusion, we demonstrate that innate immune prolonged hyperactivation is related to platelet/megakaryocyte over-expression in the lung.
Conclusions: Microthrombosis in deadly COVID-19+ lung disease is associated with an increase in the number of CD61+ platelets and megakaryocytes in the pulmonary interstitium, as well as their functional activation; this phenomenon is associated with increased expression of innate immunity TLR2+ cells, which binds the SARS-CoV-2 E protein, and significantly with the persistence of the Spike-S1 viral sequence.

Keywords: ARDS; CD61; SARS-CoV-2; TRL-2; TRLs; lethal COVID-19; lung disease; megakaryocytes; micro-thrombosis.

 
Back
Top Bottom